sr141716 has been researched along with 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1h-1,2,4-triazole in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarado, M; de Fonseca, FR; Decara, J; Elguero, J; Fernández-Ruiz, J; Gómez-Cañas, M; Gómez-Ruiz, M; Goya, P; Hernandez-Folgado, L; Jagerovic, N; Luque, MJ; Serrano, A | 1 |
| Chorvat, RJ | 1 |
| Abellán, G; Bilbao, A; Cippitelli, A; Gómez, R; Goya, P; Hernández-Folgado, L; Jagerovic, N; Macias, M; Navarro, M; Pavon, FJ; Rodríguez de Fonseca, F; Rodríguez-Franco, MA; Serrano, A | 1 |
| Bermúdez-Silva, FJ; de Fonseca, FR; Goya, P; Hernández-Folgado, L; Jagerovic, N; Macías, M; Pavón, FJ; Pérez-Valero, V; Serrano, A | 1 |
| Alen, F; Crespo, I; de Fonseca, FR; de Heras, RG; Goya, P; Jagerovic, N; Orio, L; Ramírez-López, MT | 1 |
2 review(s) available for sr141716 and 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1h-1,2,4-triazole
| Article | Year |
|---|---|
Peripherally restricted CB1 receptor blockers.
Topics: Animals; Brain; Cocaine; Drug Discovery; Humans; Liver Diseases; Metabolic Diseases; Morpholines; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Sulfonamides | 2013 |
Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.
Topics: Animals; Anorexia; Anti-Obesity Agents; Biological Availability; Brain; Cannabinoids; Central Nervous System; Drug Synergism; Eating; Endocannabinoids; Energy Metabolism; Feeding Behavior; Obesity; Oleic Acids; Piperidines; Pyrazoles; Rats; Rats, Zucker; Receptor, Cannabinoid, CB1; Rimonabant; Triazoles | 2008 |
3 other study(ies) available for sr141716 and 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1h-1,2,4-triazole
| Article | Year |
|---|---|
Novel antiobesity agents: synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21.
Topics: Animals; Anti-Obesity Agents; Cannabinoids; Eating; Humans; Male; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2013 |
Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21.
Topics: Animals; Anti-Obesity Agents; Blood-Brain Barrier; Brain; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cyclohexanes; Cyclohexanols; Eating; Ethanol; Feeding Behavior; Male; Maze Learning; Membranes, Artificial; Motor Activity; Permeability; Phenols; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rats, Zucker; Rimonabant; Self Administration; Triazoles | 2006 |
Ghrelin-induced orexigenic effect in rats depends on the metabolic status and is counteracted by peripheral CB1 receptor antagonism.
Topics: Animals; Eating; Ghrelin; Male; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Triazoles | 2013 |